Skip to main content
TipRanks
Go Ultimate75% OFF

MRT Inc. (6034) AI Stock Analysis

1 Followers
JP:6034

MRT Inc.

(TSE/TYO:6034)

Select Model
Rating:46Neutral
Price Target:JPY 478.00▲(0.84% Upside)
Action:reiterated
Date:11/18/26

The overall score is weighed down significantly by a very weak technical trend, with the stock in a clear downtrend across all major moving averages. The company's financial health is a tale of two stories: a rock-solid, nearly debt-free balance sheet provides a safety net, but this is undermined by a contracting business with declining revenue and razor-thin, volatile profitability. The elevated P/E ratio adds further risk, as the valuation appears unsupported by the company's current growth trajectory.

Positive Factors
Conservative Balance SheetVery low leverage gives MRT financial resilience and limits the burden of interest and refinancing obligations. A stable equity base also provides capacity to absorb operating volatility or support investment, preserving strategic flexibility over the next several quarters.
Negative Factors
Revenue ContractionDeclining revenue signals that MRT is not currently expanding its top line, limiting operating leverage and making profit improvement harder to sustain. Continued contraction over the next several quarters could reduce the benefits of stable gross margins and pressure resource allocation.

MRT Inc. (6034) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%JP:6034-28.72%EWJ+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 2.62B
Dividend Yield
―
Average Volume (3M)
7,318
Price to Earnings (P/E)
26.6
Beta (1Y)
0.40
Revenue Growth
-6.69%
EPS Growth
―
Country
Japan
Employees
307
Sector
Healthcare
Sector Strength
51
Industry
Specialty Business Services

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. operates a medical information platform. It provides Gaikin, a recruitment service specializing in part-time physicians; career, a job change support service for doctors; re:ray, a one stop outsourcing service; Door., an app to connect netwo...

MRT Inc. Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is a major strength with very low debt (D/E 0.09), providing stability. However, the income statement shows fragile, low-single-digit profitability on declining revenue, and cash flow generation is positive but inconsistent and trending lower. The strong balance sheet is offset by weak and volatile operating results.

Income Statement

35Negative

Balance Sheet

78Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.99B4.19B4.17B5.41B8.74B4.47B
Gross Profit2.49B2.60B2.48B3.27B5.41B3.37B
EBITDA367.54M331.35M165.42M1.20B3.16B1.61B
Net Income81.33M55.77M-309.16M518.36M2.16B774.49M
Balance Sheet
Total Assets6.37B6.48B6.75B6.47B8.16B4.98B
Cash, Cash Equivalents and Short-Term Investments1.53B1.67B2.61B3.78B4.89B1.01B
Total Debt439.08M552.97M1.05B641.79M875.86M1.04B
Total Liabilities1.62B1.83B2.12B1.76B3.67B2.69B
Stockholders Equity4.75B4.65B4.52B4.58B4.39B2.22B
Cash Flow
Free Cash Flow271.99M409.83M461.79M-208.76M4.50B-308.61M
Operating Cash Flow293.17M417.84M503.04M-193.58M4.51B-298.89M
Investing Cash Flow-515.40M-623.37M-1.84B-243.61M-431.11M-206.51M
Financing Cash Flow-438.56M-730.16M161.77M-669.19M-203.98M-67.49M

MRT Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price474.00

Price Trends

50DMA548.76Negative
100DMA590.76Negative
200DMA611.87Negative

Market Momentum

MACD-19.17Negative
RSI31.23Neutral
STOCH41.14Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 474.00 is below the 20-day moving average (MA) of 500.10, below the 50-day MA of 548.76, and below the 200-day MA of 611.87, indicating a bearish trend. The MACD of -19.17 indicates Negative momentum. The RSI at 31.23 is Neutral, neither overbought nor oversold. The STOCH value of 41.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.

MRT Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:6034 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3628JP:362854NeutralJPY 9.10B96.64――6.18%95.42%
JP:9218JP:921852NeutralJPY 7.90B30.05―1.33%34.18%-32.29%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:6034JP:603446NeutralJPY 2.64B26.61――-6.69%―
JP:4438JP:443841NeutralJPY 2.15B-4.66――34.13%35.54%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%JP:6034JP:3628JP:4438JP:9218JP:366ADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6034 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6034MRT Inc.474.00-198.00-29.46%
JP:3628Data Horizon Co., Ltd.720.00210.0041.18%
JP:4438Welby Inc.252.00-52.00-17.11%
JP:9218Mental Health Technologies Co. Ltd.752.00-91.25-10.82%
JP:366AWellness Communications Corporation1045.00-185.66-15.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026